A phase II trial of high-dose gemcitabine (GEM) plus cisplatin (CDDP) in advanced non small cell lung cancer(NSCLC).: Preliminary results.

被引：0
|
作者：
Isla, D [1 ]
Mayordom, JI [1 ]
Yubero, A [1 ]
Cajal, R [1 ]
Bueso, P [1 ]
Herráez, J [1 ]
Martí, JL [1 ]
Murillo, L [1 ]
Sáenz, A [1 ]
Escudero, P [1 ]
García-Prats, MD [1 ]
Tres, A [1 ]
机构：
[1] Univ Zaragoza, Div Med Oncol, Clin Hosp, Zaragoza, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S67 / S67
页数：1
相关论文
共 50 条
  • [31] Phase I/II trial of gemcitabine (G) administered every other week plus cisplatin (P) in advanced non-small cell lung cancer (NSCLC): final results
    Nelli, F
    De Marinis, F
    Ariganello, O
    Belli, R
    Cipri, A
    Diana, F
    Lampignano, M
    Paoluzzi, L
    Martelli, O
    Migliorino, MR
    Di Molfetta, M
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 410 - 411
  • [32] Gemcitabine and cisplatin for advanced non-small cell lung cancer (NSCLC)
    Casal, J
    Grande, C
    Caeiro, M
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1083 - 1083
  • [33] Phase II pharmacogenomic trial of IV vinorelbine (V), gemcitabine (G) and cisplatin (P) in advanced non-small-cell lung cancer (NSCLC) -: Preliminary results of efficacy and safety
    Aranda, Isidoro Barneto
    Ramos, Antonio Rueda
    Caro, Reyes Bernabe
    Magan, Begona Medina
    Mediavilla, Manuel Noguer
    Perianez, Alvaro Montano
    ANNALS OF ONCOLOGY, 2006, 17 : 238 - 238
  • [34] Results of high dose of gemcitabine plus cisplatin combination in metastatic non-small cell lung cancer
    Mayadagli, A
    Cepni, K
    Ozkan, A
    Ozseker, N
    Tepetam, H
    LUNG CANCER, 2005, 49 : S258 - S258
  • [35] A PHASE-II STUDY OF HIGH-DOSE EPIRUBICIN PLUS CISPLATINUM IN ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC)
    MARTONI, A
    GUARALDI, M
    CASADIO, M
    BUSUTTI, L
    PANNUTI, F
    ANNALS OF ONCOLOGY, 1992, 3 (10) : 864 - 866
  • [36] Brachytherapy plus chemotherapy in advanced non small cell lung cancer (NSCLC) phase II trial
    Grigorescu, A
    Bacinschi, X
    Radoi, S
    Ciocaltei, V
    LUNG CANCER, 2005, 49 : S380 - S380
  • [37] Phase II trial of gemcitabine, docetaxel, and cetuximab in advanced non-small-cell lung cancer (NSCLC)
    Rubinsak, J. R.
    Spigel, D. R.
    Hainsworth, J. D.
    Webb, C.
    Inhorn, R. C.
    Infante, J. R.
    Yardley, D. A.
    Burris, H. A., III
    Vazquez, E. R.
    Greco, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [38] Preliminary results of a multicentre phase II study with gemcitabine monotherapy in the elderly patients with advanced non small cell lung cancer (NSCLC)
    Tibaldi, C
    Ricci, S
    Bonifazi, F
    Fioretto, ML
    Bertuccelli, M
    Petruzzelli, S
    Galli, L
    Antonuzzo, A
    Andrei, A
    Tavanti, L
    Giallombardo, A
    Chiavacci, A
    Pegna, AL
    Conte, PF
    ANNALS OF ONCOLOGY, 1998, 9 : 83 - 83
  • [39] Concurrent chemoradiotherapy with Gemcitabine for locally advanced non-small cell lung cancer (NSCLC): Preliminary results of a phase II study
    Athanasiou, E
    Cyrgias, G
    Boinis, K
    Samantas, E
    Christodoulidou, M
    Tamvaki, F
    Panoussaki, E
    ANNALS OF ONCOLOGY, 1998, 9 : 97 - 97
  • [40] Endostar plus gemcitabine/cisplatin (GP) with maintenance endostar as first-line therapy for advanced non-small cell lung cancer (NSCLC): Preliminary results of a phase II study
    Lu, You
    Huang, Meijuan
    Fan, Qingxia
    Wu, Qi
    Wang, Jin
    Li, Lu
    Zhang, Xi
    Guo, Chengye
    Li, Wenhui
    Peng, Feng
    Ouyang, Xuenong
    Yu, Ding
    Cai, Xiaohong
    Xu, Yong
    Hou, Mei
    Luo, Rongcheng
    Zhang, Tao
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345